Total Debt
$5.9M
Net Debt
-$155.8M
Inhibrx Biosciences Inc. currently has $5.9M in total debt. Net debt is -$155.8M after cash offsets. This 'Net Cash' position indicates exceptional financial strength.
Financial Fundamentals
INBX • Quarterly Data • 5Y View
| Date | Total Debt ($B) | Cash & Inv. ($B) | Net Debt ($B) | Total Assets | Debt/Assets |
|---|---|---|---|---|---|
| 2026-03-31 | 0.01 | 0.16 | -0.16Net Cash | 0.18 | 3.2% |
| 2025-12-31 | 0.11 | 0.12 | -0.02Net Cash | 0.15 | 73.1% |
| 2025-09-30 | 0.01 | 0.15 | -0.15Net Cash | 0.18 | 3.9% |
| 2025-06-30 | 0.11 | 0.19 | -0.08Net Cash | 0.21 | 50.3% |
| 2025-03-31 | 0.11 | 0.22 | -0.11Net Cash | 0.24 | 43.9% |
| 2024-12-31 | 0.01 | 0.15 | -0.14Net Cash | 0.18 | 4.5% |
| 2024-09-30 | 0.00 | 0.20 | -0.19Net Cash | 0.22 | 0.8% |
| 2024-06-30 | 0.00 | 0.23 | -0.22Net Cash | 0.26 | 0.8% |
| 2024-03-31 | 0.21 | 0.25 | -0.04Net Cash | 0.29 | 73.1% |
| 2023-12-31 | 0.21 | 0.28 | -0.07Net Cash | 0.31 | 68.3% |
| 2023-09-30 | 0.21 | 0.34 | -0.13Net Cash | 0.37 | 55.6% |
| 2023-06-30 | 0.21 | 0.19 | 0.02 | 0.21 | 97.9% |
| 2023-03-31 | 0.21 | 0.23 | -0.03Net Cash | 0.25 | 81.2% |
| 2022-12-31 | 0.21 | 0.27 | -0.07Net Cash | 0.29 | 71.2% |
| 2022-09-30 | 0.17 | 0.15 | 0.03 | 0.16 | 104.7% |
| 2022-06-30 | 0.18 | 0.18 | -0.00Net Cash | 0.19 | 90.9% |
| 2022-03-31 | 0.12 | 0.14 | -0.03Net Cash | 0.16 | 71.6% |
| 2021-12-31 | 0.07 | 0.13 | -0.06Net Cash | 0.15 | 48.0% |
| 2021-09-30 | 0.08 | 0.11 | -0.04Net Cash | 0.13 | 59.7% |
| 2021-06-30 | 0.08 | 0.13 | -0.05Net Cash | 0.14 | 54.4% |
| 2021-03-31 | 0.04 | 0.11 | -0.07Net Cash | 0.12 | 30.0% |
| 2020-12-31 | 0.04 | 0.13 | -0.09Net Cash | 0.14 | 26.1% |
| 2020-09-30 | 0.02 | 0.13 | -0.11Net Cash | 0.14 | 13.1% |
| 2020-06-30 | 0.01 | 0.01 | 0.01 | 0.02 | 50.6% |
| 2020-03-31 | 0.04 | 0.00 | 0.04 | 0.02 | 255.3% |
| 2019-12-31 | 0.04 | 0.01 | 0.03 | 0.03 | 157.5% |
| 2019-06-30 | 0.04 | 0.03 | 0.01 | 0.05 | 82.9% |
| 2019-03-31 | 0.02 | 0.01 | 0.01 | 0.02 | 69.3% |
| 2018-12-31 | 0.01 | 0.00 | 0.01 | 0.01 | 95.1% |
| 2018-03-31 | 0.00 | 0.01 | -0.01Net Cash | 0.00 | — |
| 2017-12-31 | 0.01 | 0.01 | 0.00 | 0.02 | 85.0% |